Target intelligence / Profile preview

Influenza A virus H10 hemagglutinin stem domain (H10 HA stem)

Target
H10 HA stem
Molecular classification
Viral surface glycoprotein, Fusion protein, Type I transmembrane protein
01

Overview

The Influenza A virus H10 hemagglutinin (HA) stem domain is a highly conserved region of the HA surface glycoprotein, which is essential for the entry of the influenza virus into host cells (NIH, 2020). Unlike the immunodominant globular head domain that undergoes rapid antigenic drift, the stem domain—primarily composed of the HA2 subunit and parts of the HA1 subunit—remains relatively stable across different strains and subtypes within Group 2 influenza viruses, including H10 (TandfOnline, 2023). Its primary biological function is to mediate the fusion of the viral envelope with the host endosomal membrane through a pH-triggered conformational change (NIH, 2015). This conservation makes the H10 HA stem domain a critical target for the development of broadly neutralizing antibodies (bnAbs) and universal influenza vaccines (NIH, 2018). Therapeutic agents targeting this domain, such as the monoclonal antibody MEDI8852, work by binding to the stem and preventing the structural rearrangements necessary for membrane fusion, thereby neutralizing the virus (NIH, 2020). Additionally, some stem-binding antibodies can inhibit viral egress by sterically hindering the activity of the nearby neuraminidase protein (NIH, 2015).

Other names
H10 hemagglutinin stalk domainH10 HA2 domainH10 HA stemInfluenza A H10 stalkH10 hemagglutinin stem
02

Mechanism of action

Inhibition of the pH-induced conformational change of the hemagglutinin stem, which prevents the fusion of the viral envelope with the host cell endosomal membrane (NIH, 2020). Some antibodies also provide protection through antibody-dependent cellular cytotoxicity (ADCC) or by sterically hindering neuraminidase activity to prevent viral egress (NIH, 2015).

03

Biological functions

Membrane fusionViral entryViral egress
04

Disease associations

Infection
05

Safety considerations

Immunosubdominance of the stem domainMetastability of the stem region challenging vaccine designPotential for viral escape mutationsTheoretical risk of antibody-dependent enhancement (ADE)
06

Interacting drugs

MEDI8852

4 more in the full profile.

07

Biomarkers

Anti-HA stem antibody titersMicroneutralization assay titers

Beyond the preview

Go deeper on Influenza A virus H10 hemagglutinin stem domain (H10 HA stem).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A virus H10 hemagglutinin stem domain (H10 HA stem).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call